Ositab is one of the recommended brands in the oncology division that manage the EGFR mutated NSCLC (Non-small cell lung cancer) in patients who have already progressed on or after taking EGFR TKI therapy. It comes in two dose forms and is prescribed accordingly based on the clinical condition of the patient. Click on the appropriate link below to view more details like uses, composition, and description of the products.
Palbib is one of the recommended brands in the Oncology division that treats advanced or metastatic breast cancer. It comes in three doses and is prescribed based on the clinical condition of the patient. Click on the appropriate link below to view more details like uses, composition, and description of the products.
To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.
Plot Nos. M-22 & M-25; Motanga Industrial Park, S/Jongkhar, Bhutan
Plot Nos. M-22 & M-25; Motanga Industrial Park, S/Jongkhar, Bhutan
